Selegiline orally disintegrating tablet - FP PharmaceuticalAlternative Names: Efupi; FPF 1100 NW
Latest Information Update: 16 Jun 2016
At a glance
- Originator FP Pharmaceutical Corp
- Class Antiparkinsonians; Phenethylamines
- Mechanism of Action Monoamine oxidase B inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Parkinson's disease
Most Recent Events
- 03 Jun 2016 Chemical information added